Evaluation of the association between clinical parameters and ADAM33 and ORMDL3 asthma gene single-nucleotide polymorphisms with the severity of COVID-19.

Khoramipour, Mahsa; Jalali, Amir; Abbasi, Bahareh; Hadi Abbasian, Mohammad

Khoramipour, Mahsa; Jalali, Amir; Abbasi, Bahareh; Hadi Abbasian, Mohammad.

Afiliação

Khoramipour M; Department of Biology, Faculty of Sciences, Arak University, Arak, Iran.
Jalali A; Department of Biology, Faculty of Sciences, Arak University, Arak, Iran. Electronic address: a-jalali@araku.ac.ir.
Abbasi B; Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology, Tehran, Iran.
Hadi Abbasian M; Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology, Tehran, Iran.

Int Immunopharmacol ; 123: 110707, 2023 Oct.

Article em En | MEDLINE | ID: mdl-37499392

Assuntos

Asma; COVID-19; Humanos; Polimorfismo de Nucleotídeo Único; Predisposição Genética para Doença; COVID-19/genética; SARS-CoV-2; Asma/genética; Proteínas de Membrana/genética; Proteínas ADAM/genética

Palavras-chave

ADAM33; Asthma; COVID-19; ORMDL3; Polymorphisms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Int Immunopharmacol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google